• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和糖尿病犬体内胰岛素地特胰岛素的时间-作用曲线。

Time-action profiles of insulin detemir in normal and diabetic dogs.

机构信息

Department of Veterinary Nursing and Technology, School of Veterinary Medicine, Nippon Veterinary and Life Science University, 1-7-1 Kyonancho, Musashino, Tokyo 180-8602, Japan.

出版信息

Res Vet Sci. 2011 Jun;90(3):396-403. doi: 10.1016/j.rvsc.2010.07.001. Epub 2010 Aug 12.

DOI:10.1016/j.rvsc.2010.07.001
PMID:20708207
Abstract

Insulin detemir is the first member of a new class of long-acting soluble insulin analogues capable of maintaining the basal level of insulin in humans. In this preliminary study, we investigated the time-action profiles of insulin detemir in normal and diabetic dogs since the use of insulin detemir in canines has yet to be determined. Eight animals were used in our study (three normal and five insulin dependent diabetic dogs). Time-action profiles of insulin detemir were monitored in normal dogs using an artificial pancreas apparatus under euglycemic condition. Blood sampling was performed at 2h intervals post feeding, with insulin administration, in insulin dependent diabetic dogs. Time-action profiles of insulin detemir, in normal dogs, demonstrated that insulin detemir is a long-lasting preparation similar to what has been observed in humans. A pronounced peak was detected at 8-10h while the glucose-lowering effect lasted for over 24h after insulin injection, thus illustrating its longer prolonged peak activity time. Furthermore, intensive glycemic control was achieved with insulin detemir in insulin dependent diabetic dogs, using a lower dosage than NPH insulin and insulin glargine therapeutic doses. Our results indicate that insulin detemir has a greater effect than either NPH insulin or insulin glargine in canines, requiring a lower dose than either insulin preparation. However, using insulin detemir also carries a higher risk of inducing hypoglycemia as compared to either NPH insulin or insulin glargine.

摘要

胰岛素地特胰岛素是新型长效可溶性胰岛素类似物中的第一个成员,能够维持人类的基础胰岛素水平。在这项初步研究中,我们研究了胰岛素地特胰岛素在正常和糖尿病犬中的时间-作用曲线,因为尚未确定在犬中使用胰岛素地特胰岛素。我们的研究使用了 8 只动物(3 只正常和 5 只胰岛素依赖型糖尿病犬)。在正常犬中,使用人工胰腺装置在血糖正常的情况下监测胰岛素地特胰岛素的时间-作用曲线。在胰岛素依赖型糖尿病犬中,在喂食后 2 小时间隔进行采血,并给予胰岛素。在正常犬中,胰岛素地特胰岛素的时间-作用曲线表明,胰岛素地特胰岛素是一种长效制剂,与在人类中观察到的情况相似。在 8-10 小时时检测到明显的峰值,而在注射胰岛素后,其降血糖作用持续超过 24 小时,因此表明其延长的峰值活性时间更长。此外,与 NPH 胰岛素和甘精胰岛素治疗剂量相比,在胰岛素依赖型糖尿病犬中使用胰岛素地特胰岛素可以实现更密集的血糖控制,所需剂量低于 NPH 胰岛素或甘精胰岛素。我们的结果表明,与 NPH 胰岛素或甘精胰岛素相比,胰岛素地特胰岛素在犬中具有更大的作用,所需剂量低于这两种胰岛素制剂。然而,与 NPH 胰岛素或甘精胰岛素相比,使用胰岛素地特胰岛素也会增加低血糖的风险。

相似文献

1
Time-action profiles of insulin detemir in normal and diabetic dogs.正常和糖尿病犬体内胰岛素地特胰岛素的时间-作用曲线。
Res Vet Sci. 2011 Jun;90(3):396-403. doi: 10.1016/j.rvsc.2010.07.001. Epub 2010 Aug 12.
2
Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus.1型糖尿病患者中地特胰岛素和中性鱼精蛋白锌胰岛素的剂量-反应比例关系及较低的患者内变异性。
Exp Clin Endocrinol Diabetes. 2007 Jul;115(7):461-7. doi: 10.1055/s-2007-976512.
3
Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.中效和长效胰岛素:中性鱼精蛋白锌胰岛素、甘精胰岛素和地特胰岛素的综述
Curr Med Res Opin. 2006 Dec;22(12):2613-9. doi: 10.1185/030079906X154178.
4
Synthetic insulin analogs and their use in dogs and cats.合成胰岛素类似物及其在犬猫中的应用。
Vet Clin North Am Small Anim Pract. 2010 Mar;40(2):297-307. doi: 10.1016/j.cvsm.2009.11.001.
5
Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.白蛋白结合基础胰岛素类似物(地特胰岛素和NN344):2型糖尿病患者中的时间-作用曲线相似,但变异性低于甘精胰岛素。
Diabetes Obes Metab. 2007 May;9(3):290-9. doi: 10.1111/j.1463-1326.2006.00685.x.
6
[Insulin analogues: place of detemir (Levemir)].胰岛素类似物:地特胰岛素(来得时)的地位
J Pharm Belg. 2006;61(2):58-62.
7
Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.1 型糖尿病患者运动后的血糖和低血糖:三种基础胰岛素的比较。
Diabet Med. 2009 Oct;26(10):1027-32. doi: 10.1111/j.1464-5491.2009.02807.x.
8
Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes.稳态条件下的地特胰岛素:1型糖尿病患者每日两次给药时无蓄积且随着时间推移代谢效应恒定。
Diabet Med. 2006 May;23(5):522-8. doi: 10.1111/j.1464-5491.2006.01839.x.
9
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.长效胰岛素类似物与中性鱼精蛋白锌人胰岛素治疗2型糖尿病的比较:一项荟萃分析。
Diabetes Res Clin Pract. 2008 Aug;81(2):184-9. doi: 10.1016/j.diabres.2008.04.007. Epub 2008 May 20.
10
Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.与中性精蛋白锌胰岛素相比,地特胰岛素在2型糖尿病患者中具有更低的空腹血糖受试者内变异性以及更低的体重增加。
Diabetes Obes Metab. 2005 Jan;7(1):56-64. doi: 10.1111/j.1463-1326.2004.00373.x.

引用本文的文献

1
A dose titration protocol for once-daily insulin glargine 300 U/mL for the treatment of diabetes mellitus in dogs.每日一次胰岛素甘精 300U/mL 剂量滴定方案治疗犬糖尿病。
J Vet Intern Med. 2024 Jul-Aug;38(4):2120-2128. doi: 10.1111/jvim.17106. Epub 2024 Jun 3.
2
Insulins for the long term management of diabetes mellitus in dogs: a review.用于犬糖尿病长期管理的胰岛素:综述
Canine Med Genet. 2022 Feb 14;9(1):1. doi: 10.1186/s40575-022-00114-9.
3
Day-to-day variability of porcine lente, insulin glargine 300 U/mL and insulin degludec in diabetic dogs.
猪长效胰岛素、甘精胰岛素 300U/mL 和地特胰岛素在糖尿病犬中的日变异性。
J Vet Intern Med. 2021 Sep;35(5):2131-2139. doi: 10.1111/jvim.16178. Epub 2021 Jul 9.
4
The effect of Insulin Degludec on glycemic control in diabetic cats over a 12-month period.在 12 个月的时间里,德谷胰岛素对糖尿病猫血糖控制的影响。
J Vet Med Sci. 2020 Jun 16;82(6):695-698. doi: 10.1292/jvms.19-0309. Epub 2020 Apr 20.
5
Time-action profiles of insulin degludec in healthy dogs and its effects on glycemic control in diabetic dogs.德谷胰岛素在健康犬中的时效曲线及其对糖尿病犬血糖控制的影响。
J Vet Med Sci. 2018 Nov 23;80(11):1720-1723. doi: 10.1292/jvms.17-0714. Epub 2018 Oct 11.
6
Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.使用强化血糖控制方案管理的糖尿病猫中地特胰岛素的评估。
J Feline Med Surg. 2012 Aug;14(8):566-72. doi: 10.1177/1098612X12446211. Epub 2012 May 2.
7
Evaluation of artificial pancreas technology for continuous blood glucose monitoring in dogs.犬类连续血糖监测的人工胰腺技术评估
J Artif Organs. 2011 Jun;14(2):133-9. doi: 10.1007/s10047-011-0560-1. Epub 2011 Apr 14.